Sky Labs (스카이랩스) entered the KOSDAQ market on the 4th, announcing its intention to expand both domestic and international sales of its ring‑type cuffless blood‑pressure monitor. The company, a digital health firm, develops the device using proprietary hardware and AI algorithms to collect and analyze biometric data. Sky Labs also outlined a long‑term strategy to evolve into a medical‑data production platform that handles multiple biosignals. Its flagship product, the "Cart Bipi Pro" cuffless monitor, is central to this plan.
The listing marks a step toward broader global market outreach and diversification of its business portfolio, positioning Sky Labs as a potential key player in the emerging medical‑device and health‑data sectors.
市場分析2026年9月16日•3分で読めます
Sky Labs Lists on KOSDAQ, Plans Expansion of Cuffless Blood Pressure Platform
Sky Labs has debuted on KOSDAQ, aiming to grow its ring‑type cuffless blood‑pressure monitor domestically and abroad while targeting a broader multi‑bio‑signal medical data platform.
Pharmacountryチームがまとめました · 出典： KPA News
トピック：
評価
(0)
(0)
(0)
(0)
(0)
評価を残す